Posted in | Medical Robotics

Intravascular Robotics Provider Hansen Medical to Participate at Piper Jaffray Healthcare Conference

Hansen Medical, Inc, a global leader in intravascular robotics, today announced that President and CEO, Bruce Barclay, is scheduled to present at the 24th Annual Piper Jaffray Healthcare Conference. The conference is being held November 27-28, 2012, at the New York Palace Hotel, in New York, NY. Hansen Medical is scheduled to present on Wednesday, November 28, 2012 at 2:30 p.m. Eastern Time.

Hansen Medical will provide a live webcast of the audio presentation. Interested parties may access the live webcast by visiting the investor relations section of Hansen Medical's web site at www.hansenmedical.com. A replay of the webcast will be available at the site after the presentation.

Hansen Medical, Inc., based in Mountain View, California, is the global leader in intravascular robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The Company's Magellan™ Robotic System, NorthStar™ Robotic Catheter and related accessories, which are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices, have undergone both CE marking and 510(k) clearance and are commercially available in the European Union, and the U.S. In the European Union, the Company's Sensei® X Robotic Catheter System and Artisan Control Catheter are cleared for use during electrophysiology (EP) procedures, such as guiding catheters in the treatment of atrial fibrillation (AF), and the Lynx® Robotic Ablation Catheter is cleared for the treatment of AF. This robotic catheter system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. In the U.S. the Company's Sensei X Robotic Catheter System and Artisan Control Catheter were cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in EP procedures. In the United States, the Sensei System is not approved for use in guiding ablation procedures; this use remains experimental. The U.S. product labeling therefore provides that the safety and effectiveness of the Sensei X System and Artisan Control Catheter for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including AF, have not been established.

Source: http://www.hansenmedical.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hansen Medical. (2019, February 20). Intravascular Robotics Provider Hansen Medical to Participate at Piper Jaffray Healthcare Conference. AZoRobotics. Retrieved on January 17, 2020 from https://www.azorobotics.com/News.aspx?newsID=3459.

  • MLA

    Hansen Medical. "Intravascular Robotics Provider Hansen Medical to Participate at Piper Jaffray Healthcare Conference". AZoRobotics. 17 January 2020. <https://www.azorobotics.com/News.aspx?newsID=3459>.

  • Chicago

    Hansen Medical. "Intravascular Robotics Provider Hansen Medical to Participate at Piper Jaffray Healthcare Conference". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=3459. (accessed January 17, 2020).

  • Harvard

    Hansen Medical. 2019. Intravascular Robotics Provider Hansen Medical to Participate at Piper Jaffray Healthcare Conference. AZoRobotics, viewed 17 January 2020, https://www.azorobotics.com/News.aspx?newsID=3459.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit